Clinical trial
A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection…
NCT00000966 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00000966 |
|---|---|
| Title | A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS |
| Official title | A Dose-Escalation, Phase I/II Study of Oral Azithromycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS |
| Lead sponsor | Pfizer, Industry |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Toxoplasmosis, Cerebral, HIV Infections |
| Intervention type | Drug |
| Interventions | Azithromycin, Pyrimethamine, Leucovorin calcium |
| Enrollment | 45 |
| First posted | Aug 31, 2001 |
| Last update posted | Aug 26, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: